Curiox BioSystems Co Ltd
KOSDAQ:445680
Cash Flow Statement
Cash Flow Statement
Curiox BioSystems Co Ltd
| Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Net Income |
(12 206)
|
(16 224)
|
(8 089)
|
(9 050)
|
(24 236)
|
(23 247)
|
|
| Depreciation & Amortization |
2 657
|
3 157
|
2 119
|
2 158
|
2 208
|
2 211
|
|
| Stock-Based Compensation |
1 635
|
1 883
|
777
|
2 141
|
774
|
925
|
|
| Other Non-Cash Items |
(1 528)
|
(417)
|
(4 228)
|
(3 530)
|
11 962
|
11 350
|
|
| Cash Taxes Paid |
17
|
30
|
50
|
58
|
20
|
27
|
|
| Cash Interest Paid |
40
|
49
|
35
|
34
|
30
|
26
|
|
| Change in Working Capital |
979
|
479
|
500
|
(88)
|
(692)
|
(425)
|
|
| Cash from Operating Activities |
(10 098)
N/A
|
(13 006)
-29%
|
(9 698)
+25%
|
(10 511)
-8%
|
(10 758)
-2%
|
(10 111)
+6%
|
|
| Investing Cash Flow | |||||||
| Capital Expenditures |
(94)
|
(94)
|
(258)
|
(229)
|
(233)
|
(255)
|
|
| Other Items |
3 219
|
3 203
|
(4 017)
|
(9 018)
|
(1 992)
|
(2 974)
|
|
| Cash from Investing Activities |
3 125
N/A
|
3 109
-1%
|
(4 275)
N/A
|
(9 247)
-116%
|
(2 225)
+76%
|
(3 230)
-45%
|
|
| Financing Cash Flow | |||||||
| Net Issuance of Common Stock |
0
|
18 137
|
291
|
364
|
0
|
891
|
|
| Net Issuance of Debt |
(475)
|
19 430
|
19 600
|
19 586
|
19 591
|
(414)
|
|
| Other |
75
|
(28)
|
(30)
|
0
|
25
|
(13)
|
|
| Cash from Financing Activities |
17 564
N/A
|
37 539
+114%
|
19 861
-47%
|
19 920
+0%
|
19 907
0%
|
391
-98%
|
|
| Change in Cash | |||||||
| Effect of Foreign Exchange Rates |
2
|
(68)
|
390
|
796
|
223
|
619
|
|
| Net Change in Cash |
10 593
N/A
|
27 574
+160%
|
6 279
-77%
|
959
-85%
|
7 147
+645%
|
(12 331)
N/A
|
|
| Free Cash Flow | |||||||
| Free Cash Flow |
(10 192)
N/A
|
(13 100)
-29%
|
(9 956)
+24%
|
(10 740)
-8%
|
(10 991)
-2%
|
(10 366)
+6%
|
|